183 related articles for article (PubMed ID: 21979588)
21. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
22. Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degeneration.
Johns JB; Odunsi KO; Fleischman S; Azodi M; Schwartz PE
Gynecol Oncol; 1999 May; 73(2):326-30. PubMed ID: 10329056
[TBL] [Abstract][Full Text] [Related]
23. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
[TBL] [Abstract][Full Text] [Related]
24. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
[TBL] [Abstract][Full Text] [Related]
25. Gynaecology meets neurology: paraneoplastic cerebellar degeneration.
Land R; Carter J; Houghton R; Atkinson K; Dalrymple C
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):79-81. PubMed ID: 15730373
[No Abstract] [Full Text] [Related]
26. Atypical paraneoplastic syndrome associated with anti-Yo antibodies.
Finsterer J; Bodenteich A; Drlicek M
Clin Neuropathol; 2003; 22(3):137-40. PubMed ID: 12809356
[TBL] [Abstract][Full Text] [Related]
27. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
[TBL] [Abstract][Full Text] [Related]
28. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
[TBL] [Abstract][Full Text] [Related]
29. Case records of the Massachusetts General Hospital. Case 4-2007. A 56-year-old woman with rapidly progressive vertigo and ataxia.
Dalmau J; Gonzalez RG; Lerwill MF
N Engl J Med; 2007 Feb; 356(6):612-20. PubMed ID: 17287482
[No Abstract] [Full Text] [Related]
30. Fallopian tube carcinoma presenting with a brain metastasis.
Raff JP; Anderson P; Sands C; Makower D
Gynecol Oncol; 2002 May; 85(2):372-5. PubMed ID: 11972403
[TBL] [Abstract][Full Text] [Related]
31. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
[TBL] [Abstract][Full Text] [Related]
33. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
34. Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach.
Kikuchi H; Yamada T; Okayama A; Hara H; Taniwaki T; Shigeto H; Sasaki M; Iwaki T; Kira J
Fukuoka Igaku Zasshi; 2000 Apr; 91(4):104-9. PubMed ID: 10826224
[TBL] [Abstract][Full Text] [Related]
35. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
36. [Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report].
Goto A; Kusumi M; Wakutani Y; Nakaso K; Kowa H; Nakashima K
Rinsho Shinkeigaku; 2006 Feb; 46(2):144-7. PubMed ID: 16619840
[TBL] [Abstract][Full Text] [Related]
37. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
38. Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
Monstad SE; Storstein A; Dørum A; Knudsen A; Lønning PE; Salvesen HB; Aarseth JH; Vedeler CA
Clin Exp Immunol; 2006 Apr; 144(1):53-8. PubMed ID: 16542365
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
40. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]